Literature DB >> 14725588

Relapse into mania or depression following lithium discontinuation: a 7-year follow-up.

J Cavanagh1, R Smyth, G M Goodwin.   

Abstract

OBJECTIVE: We aimed to assess whether outcome followed a worse course after acute lithium withdrawal.
METHOD: Data were acquired by review of the clinical records on 14 cases and 28 controls matched for age, gender and time on lithium for about 7 years following discontinuation.
RESULTS: Significant differences were found between cases and controls. Cases experienced more episodes of depression and total affective relapse. The log-rank test revealed a significantly lower survival probability in cases than controls (P < 0.0009). However, the increased risk of recurrence was largely confined to the interval immediately after lithium discontinuation.
CONCLUSION: These results confirm that acute discontinuation of lithium leads to a high immediate relapse rate. Most of the excess morbidity over 7 years appears to be attributable to the first episode following discontinuation. Outcome was not worsened by discontinuation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14725588     DOI: 10.1046/j.1600-0447.2003.00274.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  11 in total

Review 1.  Maintenance treatment study designs in bipolar disorder: do they demonstrate that atypical neuroleptics (antipsychotics) are mood stabilizers?

Authors:  Frederick K Goodwin; Elizabeth A Whitham; S Nassir Ghaemi
Journal:  CNS Drugs       Date:  2011-10-01       Impact factor: 5.749

2. 

Authors:  Berrin Günaydın; Ömer Kurtipek
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-06-01

3.  Medication adherence in a comparative effectiveness trial for bipolar disorder.

Authors:  L G Sylvia; N A Reilly-Harrington; A C Leon; C I Kansky; J R Calabrese; C L Bowden; T A Ketter; E S Friedman; D V Iosifescu; M E Thase; M J Ostacher; M Keyes; D Rabideau; A A Nierenberg
Journal:  Acta Psychiatr Scand       Date:  2013-10-03       Impact factor: 6.392

Review 4.  Solving the antidepressant efficacy question: effect sizes in major depressive disorder.

Authors:  Paul A Vöhringer; S Nassir Ghaemi
Journal:  Clin Ther       Date:  2011-12-02       Impact factor: 3.393

Review 5.  Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations.

Authors:  Gin S Malhi; Michelle Tanious
Journal:  CNS Drugs       Date:  2011-04       Impact factor: 5.749

Review 6.  Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder.

Authors:  Alexandre Duarte Gigante; Beny Lafer; Lakshmi N Yatham
Journal:  CNS Drugs       Date:  2012-05-01       Impact factor: 5.749

Review 7.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

Review 8.  Potential mechanisms of action of lithium in bipolar disorder. Current understanding.

Authors:  Gin S Malhi; Michelle Tanious; Pritha Das; Carissa M Coulston; Michael Berk
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

9.  Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice.

Authors:  Robert K McNamara; Jeffrey R Strawn
Journal:  PharmaNutrition       Date:  2013-04

Review 10.  Separate and concomitant use of lamotrigine, lithium, and divalproex in bipolar disorders.

Authors:  Daniel Z Lieberman; Frederick K Goodwin
Journal:  Curr Psychiatry Rep       Date:  2004-12       Impact factor: 8.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.